Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”

US 8501926

Malaria vaccine

The United States of America as represented by the Secretary of the Army · Granted Aug 6, 2013 · Expires Aug 1, 2033

US 8501182

Monoclonal antibodies that react with the capsule of Bacillus anthracis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

US 8501188

Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

US 8492428

Small-molecule botulinum toxin inhibitors

The United States of America as represented by the Secretary of the Army · Granted Jul 23, 2013 · Expires Jul 18, 2033

US 8481055

Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 9, 2013 · Expires Jul 4, 2033

US 8481048

Methods for preparing immunogenic conjugates

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jul 9, 2013 · Expires Jul 4, 2033

US 8476236

Treatment of skin conditions by Dickkopf1 (DKK1)

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 2, 2013 · Expires Jun 27, 2033

US 8470342

Methods of altering an immune response induced by CpG oligodeoxynucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 25, 2013 · Expires Jun 20, 2033

US 8465917

Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jun 18, 2013 · Expires Jun 13, 2033

US 8465749

Polysaccharide-protein conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 18, 2013 · Expires Jun 13, 2033

US 8460660

Anti-mesothelin antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 11, 2013 · Expires Jun 6, 2033

US 8455652

Inhibitors for the soluble epoxide hydrolase

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

US 8454965

Method for the treatment of multiple sclerosis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

US 8455437

Method to predict and prevent oxygen-induced inflammatory tissue injury

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

US 8445216

Antibodies and immunotoxins that target human glycoprotein NMB

The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted May 21, 2013 · Expires May 16, 2033

US 8440393

Pro-angiogenic genes in ovarian tumor endothelial cell isolates

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 14, 2013 · Expires May 9, 2033

US 8440411

Differential gene expression in physiological and pathological angiogenesis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 14, 2013 · Expires May 9, 2033

US 8440206

Methods for producing an immune response to tuberculosis

The United States of America as represented by the Department of Veteran Affairs · Granted May 14, 2013 · Expires May 9, 2033

US 8435507

Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer

The United States of America as Represented by the Dept. of Veterans Affairs · Granted May 7, 2013 · Expires May 2, 2033

US 8435979

Use of imipramine blue and analogs thereof in treating cancers

The United States of America as Represented by the Dept. of Veterans Affairs · Granted May 7, 2013 · Expires May 2, 2033

US 8431176

Liquid chromatographic fraction of enzymatically polymerized flavonoid as an antioxidant

The United States of America as represented by the Secretary of the Army · Granted Apr 30, 2013 · Expires Apr 25, 2033

US 8431134

Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 30, 2013 · Expires Apr 25, 2033

US 8426574

Identification of astrovirus VA1 associated with gastroenteritis in humans

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 23, 2013 · Expires Apr 18, 2033

US 8420099

Chimeric protein for prevention and treatment of HIV infection

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 16, 2013 · Expires Apr 11, 2033